Krishna S. Gunturu

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 648 citations · Full text

Medicine, Oncology, Pharmacology +11

Gastric cancer and trastuzumab: first biologic therapy in gastric cancer

Krishna S. Gunturu, Yanghee Woo, Nike Beaubier et al. · Therapeutic Advances in Medical Oncology · 2013 · 84 citations · Full text

Medicine, Oncology, Pharmacology +16

Upfront dexrazoxane for the reduction of anthracycline-induced cardiotoxicity in adults with preexisting cardiomyopathy and cancer: a consecutive case series

Sarju Ganatra, Anju Nohria, Sachin Shah et al. · Cardio-Oncology · 2019 · 84 citations · Full text

Medicine, Oncology, Pharmacology +17

Ayurvedic herbal medicine and lead poisoning

Krishna S. Gunturu, Priyadharsini Nagarajan, Peter McPhedran et al. · Journal of Hematology & Oncology · 2011 · 65 citations · Full text

Pharmacy, Clinical Toxicology, Toxicology +17

Immunotherapy updates in pancreatic cancer: are we there yet?

Krishna S. Gunturu, Gabriela R. Rossi, Muhammad Wasif · Therapeutic Advances in Medical Oncology · 2012 · 42 citations · Full text

Medicine, Immunology, Oncology +9